| The new Swedish Prescribed Drug Register—opportunities for pharmacoepidemiological research and experience from the first six months B Wettermark, N Hammar, C MichaelFored, A Leimanis, ... Pharmacoepidemiology and drug safety 16 (7), 726-735, 2007 | 1823 | 2007 |
| The Nordic countries as a cohort for pharmacoepidemiological research K Furu, B Wettermark, M Andersen, JE Martikainen, AB Almarsdottir, ... Basic & clinical pharmacology & toxicology 106 (2), 86-94, 2010 | 633 | 2010 |
| The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden R Zarrinkoub, B Wettermark, P Wändell, M Mejhert, R Szulkin, ... European journal of heart failure 15 (9), 995-1002, 2013 | 415 | 2013 |
| The ‘wise list’–a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm LL Gustafsson, B Wettermark, B Godman, E Andersén‐Karlsson, ... Basic & clinical pharmacology & toxicology 108 (4), 224-233, 2011 | 294 | 2011 |
| Drug utilization 90%–a simple method for assessing the quality of drug prescribing U Bergman, C Popa, Y Tomson, B Wettermark, TR Einarson, H Åberg, ... European journal of clinical pharmacology 54, 113-118, 1998 | 292 | 1998 |
| The first decade with the Swedish prescribed drug register–a systematic review of the output in the scientific literature SM Wallerstedt, B Wettermark, M Hoffmann Basic & clinical pharmacology & toxicology 119 (5), 464-469, 2016 | 221 | 2016 |
| Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications B Godman, W Shrank, M Andersen, C Berg, I Bishop, T Burkhardt, ... Expert review of pharmacoeconomics & outcomes research 10 (6), 707-722, 2010 | 206 | 2010 |
| The Nordic prescription databases as a resource for pharmacoepidemiological research—a literature review B Wettermark, H Zoëga, K Furu, M Korhonen, J Hallas, M Nørgaard, ... Pharmacoepidemiology and drug safety 22 (7), 691-699, 2013 | 205 | 2013 |
| Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance B Godman, B Wettermark, M Hoffmann, K Andersson, A Haycox, ... Expert review of pharmacoeconomics & outcomes research 9 (1), 65-83, 2009 | 184 | 2009 |
| Association between proton pump inhibitor use and risk of progression of chronic kidney disease DCF Klatte, A Gasparini, H Xu, P de Deco, M Trevisan, ALV Johansson, ... Gastroenterology 153 (3), 702-710, 2017 | 171 | 2017 |
| High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden–a challenge for public health AC Carlsson, P Wändell, U Ösby, R Zarrinkoub, B Wettermark, ... BMC public health 13, 1-8, 2013 | 164 | 2013 |
| Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications B Godman, B Wettermark, M Van Woerkom, J Fraeyman, ... Frontiers in pharmacology 5, 106, 2014 | 161 | 2014 |
| Prevalence and recognition of chronic kidney disease in Stockholm healthcare A Gasparini, M Evans, J Coresh, ME Grams, O Norin, AR Qureshi, ... Nephrology Dialysis Transplantation, gfw354, 2016 | 159 | 2016 |
| Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation T Forslund, B Wettermark, P Hjemdahl European journal of clinical pharmacology 72, 329-338, 2016 | 155 | 2016 |
| Barriers for access to new medicines: searching for the balance between rising costs and limited budgets B Godman, A Bucsics, P Vella Bonanno, W Oortwijn, CC Rothe, A Ferrario, ... Frontiers in Public Health 6, 328, 2018 | 153 | 2018 |
| Policies to enhance prescribing efficiency in Europe: findings and future implications B Godman, W Shrank, M Andersen, C Berg, I Bishop, T Burkhardt, ... Frontiers in pharmacology 1, 141, 2011 | 151 | 2011 |
| Differences in drug utilisation between men and women: a cross-sectional analysis of all dispensed drugs in Sweden D Loikas, B Wettermark, M von Euler, U Bergman, K Schenck-Gustafsson BMJ open 3 (5), e002378, 2013 | 147 | 2013 |
| Drug utilization research: methods and applications M Elseviers, B Wettermark, AB Almarsdóttir, M Andersen, R Benkö, ... John Wiley & Sons, 2016 | 143 | 2016 |
| Validation of asthma and eczema in population‐based Swedish drug and patient registers AK Örtqvist, C Lundholm, B Wettermark, JF Ludvigsson, W Ye, C Almqvist Pharmacoepidemiology and drug safety 22 (8), 850-860, 2013 | 134 | 2013 |
| Most common diseases diagnosed in primary care in Stockholm, Sweden, in 2011 P Wändell, AC Carlsson, B Wettermark, G Lord, T Cars, G Ljunggren Family practice 30 (5), 506-513, 2013 | 126 | 2013 |
